摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2(S)-(O-acetylmethyl)-4(S)-(6-amino-9H-purin-9-yl)tetrahydrofuran | 151223-85-7

中文名称
——
中文别名
——
英文名称
2(S)-(O-acetylmethyl)-4(S)-(6-amino-9H-purin-9-yl)tetrahydrofuran
英文别名
[(2S,4S)-4-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methyl acetate;[(2S,4S)-4-(6-aminopurin-9-yl)oxolan-2-yl]methyl acetate
2(S)-(O-acetylmethyl)-4(S)-(6-amino-9H-purin-9-yl)tetrahydrofuran化学式
CAS
151223-85-7
化学式
C12H15N5O3
mdl
——
分子量
277.283
InChiKey
OYTXWBMKLIINSP-IUCAKERBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    105
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2(S)-(O-acetylmethyl)-4(S)-(6-amino-9H-purin-9-yl)tetrahydrofuran亚硝酸正戊酯 作用下, 以 四氢呋喃 为溶剂, 反应 72.0h, 以55.4%的产率得到4(S)-(9H-purin-9-yl)tetrahydro-2(S)-furanmethylacetate
    参考文献:
    名称:
    Synthesis and Conformational Studies of New Purine Isodideoxynucleosides
    摘要:
    The synthesis and NMR conformational correlations (preferred syn or anti) of new isomeric dideoxynucleosides of potential antiviral interest are described. These compounds are related to the potently active anti-HIV compound, (S,S)-isodideoxy-adenosine.
    DOI:
    10.1080/07328319608002371
  • 作为产物:
    描述:
    4(S)-(6-amino-9H-purin-9-yl)-2(S)-(O-benzoylmethyl)tetrahydrofuran 在 4-二甲氨基吡啶sodium methylate三乙胺 作用下, 以 甲醇乙腈 为溶剂, 反应 2.38h, 生成 2(S)-(O-acetylmethyl)-4(S)-(6-amino-9H-purin-9-yl)tetrahydrofuran
    参考文献:
    名称:
    Novel isomeric dideoxynucleosides as potential antiviral agents
    摘要:
    Novel isomeric dideoxynucleosides with S,S absolute stereochemistry and involving the transposition of the base moiety from the normal 1'- to the 2'-position have been regiospecifically and stereospecifically synthesized. The synthetic approaches involved either direct coupling with inversion at the 2-position of a preformed dideoxygenated sugar using the base moiety as nucleophile (for purine isodideoxynucleosides) or construction of the base moiety onto a stereochemically defined amino sugar precursor (pyrimidine isodideoxynucleosides). These compounds possess extremely high stability with respect to ''glycosidic'' bond cleavage and enzymatic deamination. Antiviral data suggest that the most active compound was levorotatory S,S-isodideoxyadenosine.
    DOI:
    10.1016/s0040-4020(01)85259-5
点击查看最新优质反应信息

文献信息

  • US5231174A
    申请人:——
    公开号:US5231174A
    公开(公告)日:1993-07-27
  • Novel isomeric dideoxynucleosides as potential antiviral agents
    作者:Pascal J. Bolon、Todd B. Sells、Zoraida M. Nuesca、David F. Purdy、Vasu Nair
    DOI:10.1016/s0040-4020(01)85259-5
    日期:1994.1
    Novel isomeric dideoxynucleosides with S,S absolute stereochemistry and involving the transposition of the base moiety from the normal 1'- to the 2'-position have been regiospecifically and stereospecifically synthesized. The synthetic approaches involved either direct coupling with inversion at the 2-position of a preformed dideoxygenated sugar using the base moiety as nucleophile (for purine isodideoxynucleosides) or construction of the base moiety onto a stereochemically defined amino sugar precursor (pyrimidine isodideoxynucleosides). These compounds possess extremely high stability with respect to ''glycosidic'' bond cleavage and enzymatic deamination. Antiviral data suggest that the most active compound was levorotatory S,S-isodideoxyadenosine.
  • Synthesis and Conformational Studies of New Purine Isodideoxynucleosides
    作者:Lawrence B. Zintek、Tamera S. Jahnke、Vasu Nair
    DOI:10.1080/07328319608002371
    日期:1996.1
    The synthesis and NMR conformational correlations (preferred syn or anti) of new isomeric dideoxynucleosides of potential antiviral interest are described. These compounds are related to the potently active anti-HIV compound, (S,S)-isodideoxy-adenosine.
查看更多